|
AU2003224561A1
|
|
Use of dhea for treatment of female hypopituitarism
|
|
AU2002359177A1
|
|
Use of interleukin-6 for treatment of obesity
|
|
AU2002351560A1
|
|
Treatment of congestive heart failure
|
|
AU2316902A
|
|
Method for detecting molecules or chemical reactions by determining variation ofconductance
|
|
AU6286101A
|
|
New use
|
|
AU5689201A
|
|
Reagent for detection of biomolecules, and use thereof
|
|
AU4895301A
|
|
Treatment of hypertrophic cardiomyopathy with a substance that increases the level of growth hormone receptor antagonists
|
|
AU1425001A
|
|
New use of the jak-stat system
|
|
AU6330300A
|
|
Use of interleukin-6 in treatment of obesity and/or obesity associated disorders
|
|
AU4790800A
|
|
Treatment of acute myocardial infarction with a substance related to the growth hormone axis
|
|
CA2342794A1
|
|
Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia
|
|
AU1304600A
|
|
Use of SOCS-2 or CIS to screen for compounds enhancing growth hormone effect
|
